Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation

Autor: Ma, Sung Jun, Yu, Han, Khan, Michael, Yu, Brian, Santhosh, Sharon, Chatterjee, Udit, Gill, Jasmin, Iovoli, Austin, Farrugia, Mark, Wooten, Kimberly, Gupta, Vishal, McSpadden, Ryan, Kuriakose, Moni A, Markiewicz, Michael R, Al-Afif, Ayham, Hicks, Wesley L, Jr, Platek, Mary E, Seshadri, Mukund, Ray, Andrew D., Repasky, Elizabeth, Singh, Anurag K.
Zdroj: In Oral Oncology October 2022 133
Databáze: ScienceDirect
Externí odkaz: